Page 98 - TD-3-1
P. 98

Tumor Discovery                                               MMP-1 as a potential biomarker for gastric cancer



            51.  Miyamoto  S,  Watanabe  Y, Oikawa  R,  et al.  Analysis  of   2021;50-51:101731.
               helicobacter pylori genotypes in clinical gastric wash      doi: 10.1016/j.bpg.2021.101731
               samples. Tumour Biol. 2016;37(8):10123-10132.
                                                               62.  Qian Z, Wang J. Application of computed tomography imaging
               doi: 10.1007/s13277-016-4886-4
                                                                  in diagnosis of endocrine nerve of gastric cancer and nursing
            52.  Chae HD, Kim IH. Prognostic significance of CEA   intervention effect. World Neurosurg. 2021;149:341-351.
               expression by RT-PCR in peritoneal wash from patients with      doi: 10.1016/j.wneu.2020.10.005
               gastric cancer: Result of a 5-year follow-up after curative
               resection. Scand J Gastroenterol. 2016;51(8):956-960.  63.  Rezaei Z, Ranjbaran J, Safarpour H, et al. Identification of
                                                                  early diagnostic biomarkers via WGCNA in gastric cancer.
               doi: 10.3109/00365521.2016.1172339                 Biomed Pharmacother. 2022;145:112477.
            53.  Zhou X, Liu J, Meng A,  et al. Gastric juice piR-1245:      doi: 10.1016/j.biopha.2021.112477
               A promising prognostic biomarker for gastric cancer. J Clin
               Lab Anal. 2020;34(4):e23131.                    64.  Numakura S, Uozaki H. Low MLL2 protein expression is
                                                                  associated with fibrosis in early stage gastric cancer. In Vivo.
               doi: 10.1002/jcla.23131                            2021;35(1):603-609.
            54.  Pan Y, Zheng Y, Yang J, et al. A new biomarker for the early      doi: 10.21873/invivo.12297
               diagnosis of gastric cancer: Gastric juice-and serum-derived
               SNCG. Future Oncol. 2022;18(28):3179-3190.      65.  Guan X. Cancer metastases: Challenges and opportunities.
                                                                  Acta Pharm Sin B. 2015;5(5):402-418.
               doi: 10.2217/fon-2022-0253
                                                                  doi: 10.1016/j.apsb.2015.07.005
            55.  Lopes C, Chaves J, Ortigão R, Dinis-Ribeiro M, Pereira C.
               Gastric cancer detection by non-blood-based liquid biopsies:   66.  Fu BM. Tumor metastasis in the microcirculation. Adv Exp
               A systematic review looking into the last decade of research.   Med Biol. 2018;1097:201-218.
               United European Gastroenterol J. 2023;11(1):114-130.     doi: 10.1007/978-3-319-96445-4_11
               doi: 10.1002/ueg2.12328                         67.  Guo S, Huang J, Li G, Chen W, Li Z, Lei J. The role of
            56.  Enríquez-Sánchez LB, Gallegos-Portillo LG, Camarillo-  extracellular  vesicles  in  circulating  tumor  cell-mediated
               Cisneros J, et al. Cost-benefit of serum pepsinogen screening   distant metastasis. Mol Cancer. 2023;22(1):193.
               for gastric adenocarcinoma in the Mexican population. Rev      doi: 10.1186/s12943-023-01909-5
               Gastroenterol Mexico (Eng Ed). 2022;87(3):285-291.
                                                               68.  Burr R, Gilles C, Thompson EW, Maheswaran S. Epithelial-
               doi: 10.1016/j.rgmxen.2021.11.002                  mesenchymal plasticity in circulating tumor cells, the
            57.  Machii R, Takahashi H. Japanese cancer screening programs   precursors of metastasis. Adv Exp Med Biol. 2020;1220:11-34.
               during the COVID-19 pandemic: Changes in participation      doi: 10.1007/978-3-030-35805-1_2
               between 2017-2020. Cancer Epidemiol. 2023;82:102313.
                                                               69.  Pastushenko I, Blanpain C. EMT transition states during
               doi: 10.1016/j.canep.2022.102313                   tumor progression and metastasis.  Trends Cell Biol.
            58.  Cesaretti M, Bian AZL. In vivo medical imaging technologies:   2019;29(3):212-226.
               New possibility in diagnosis of gastric cancer. Minerva Chir.      doi: 10.1016/j.tcb.2018.12.001
               2016;71(4):270-277.
                                                               70.  Fiori ME, Di Franco S, Villanova L, Bianca P, Stassi G, De
            59.  Zhu SL, Dong J, Zhang C, Huang YB, Pan W. Application   Maria R. Cancer-associated fibroblasts as abettors of tumor
               of  machine  learning  in the  diagnosis of  gastric  cancer   progression at the crossroads of EMT and therapy resistance.
               based on noninvasive characteristics.  PLoS One.   Mol Cancer. 2019;18(1):70.
               2020;15(12):e0244869.
                                                                  doi: 10.1186/s12943-019-0994-2
               doi: 10.1371/journal.pone.0244869
                                                               71.  Zhang Y, Weinberg RA. Epithelial-to-mesenchymal
            60.  Thapa S, Fischbach LA, Delongchamp R, Faramawi MF,   transition in cancer: Complexity and opportunities.  Front
               Orloff MS. Using machine learning to predict progression   Med. 2018;12(4):361-373.
               in the gastric precancerous process in a population from
               a developing country who underwent a gastroscopy      doi: 10.1007/s11684-018-0656-6
               for  dyspeptic  symptoms.  Gastroenterol Res Pract.   72.  Phillips RM, Lam C, Wang H, Tran PT. Bittersweet tumor
               2019;2019:8321942.                                 development and progression: Emerging roles of epithelial
               doi: 10.1155/2019/8321942                          plasticity glycosylations. Adv Cancer Res. 2019;142:23-62.
                                                                  doi: 10.1016/bs.acr.2019.01.002
            61.  Leja M, Linē A. Early detection of gastric cancer beyond
               endoscopy-new methods. Best Pract Res Clin Gastroenterol.   73.  Bakir B, Chiarella AM, Pitarresi JR, Rustgi AK. EMT,


            Volume 3 Issue 1 (2024)                         10                         https://doi.org/10.36922/td.1973
   93   94   95   96   97   98   99   100   101   102   103